Mereo Biopharma Group Plc Adr (MREO)

Finanzdaten der Mereo Biopharma Group Plc Adr-Aktie (MREO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	0.50
	61.91%1.81	4.75	4.19	-	-
Research and Development	61.91%1.81	4.75	4.19	-	-
Interest Income/Expense	20.00%0.02	0.02	0.02	0.03	0.02
Operating Income/Loss	19.80%-7.03	-8.77	-8.39	-10.02	-10.50
Income/Loss From Continuing Operations Before Tax	4.26%-7.01	-6.72	-7.35	-7.02	-14.62
Income Tax Expense/Benefit	-	-	-	-	-
	4.26%-7.01	-6.72	-7.35	-7.02	-14.62
Attributable To Parent	4.26%-7.01	-6.72	-7.35	-7.02	-14.62
Basic Average Shares	0.22%803.56	801.81	-	799.95	799.44
Diluted Average Shares	0.22%803.56	801.81	-	799.95	799.44
Basic Earnings Per Share	-0.01	-0.01	-	-0.01	-0.02
Diluted Earnings Per Share	-0.01	-0.01	-	-0.01	-0.02